Adalimumab for Rheumatoid Arthritis: Considerations for Reimbursement by Third-Party Payors
Year of publication: |
2004
|
---|---|
Authors: | van de Putte, Leo ; Nichol, Michael B. |
Published in: |
Disease Management and Health Outcomes. - Springer Healthcare | Adis, ISSN 1173-8790. - Vol. 12.2004, 1, p. 1-8
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Adalimumab | Pharmacoeconomics | Reimbursement | Rheumatoid-arthritis |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Quality-of-Life Assessment in Rheumatoid Arthritis
Russell, Anthony S., (2008)
-
(2012)
-
Spalding, James R., (2006)
- More ...
-
Nichol, Michael B., (1999)
-
Cost-Benefit Analysis of First-Generation Antihistamines in the Treatment of Allergic Rhinitis
Sullivan, Patrick W., (2004)
-
The demand for statin: the effect of copay on utilization and compliance
Thiebaud, Patrick, (2008)
- More ...